LLY241227P730000
- 0.12
- -0.14-53.85%
Eli Lilly and Co Newsroom
Express News | Eli Lilly and Co China responds to the production capacity of tirzepatide: the factory operates day and night to meet patient demand.
The USA FDA has revoked the emergency use authorization for four COVID-19 antibody drugs.
On December 24, Gelonghui reported that the USA Food and Drug Administration (FDA) has revoked the emergency use authorization for four COVID-19 antibody drugs, including Eli Lilly and Co's bebtelovimab, AstraZeneca's Evusheld, GlaxoSmithKline's sotrovimab, and Regeneron's REGEN-COV. The FDA stated in a letter earlier this month that the shelf life of these drugs has expired, and due to the spread of non-susceptible variants, they have not been authorized for patient use for more than a year. According to the FDA, the four companies mentioned above do not intend to continue providing the relevant products in the USA and will notify customers and suppliers.
Express News | Eli Lilly and Co's weight-loss medication is now available for purchase on e-commerce platforms, and Eli Lilly and Co in China responded that it is a self-pay medication.
Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know
Weight-loss Drugs in 2025, Auto Industry Outlook: Market Domination
Eli Lilly's Weight Loss Med Tirzepatide Gets Endorsement From U.K.'s NICE
With EPS Growth And More, Eli Lilly (NYSE:LLY) Makes An Interesting Case
Eli Lilly's Anti-Obesity Drug Mounjaro to Be Supported by UK Public Health System for Some Patients
U.S. stocks closed higher | The three major Indexes collectively rose, with the Nasdaq increasing by nearly 1%; chip stocks surged, with Broadcom and Taiwan Semiconductor rising over 5%, and NVIDIA increasing nearly 4%.
① The Nasdaq China Golden Dragon Index rose by 0.91%; ② The PHLX Semiconductor Index rose by over 3%; ③ MicroStrategy purchased 5,262 Bitcoins; ④ The suspect in the UnitedHealth executive's murder case pleaded not guilty.
Sector Update: Health Care Stocks Advance Late Afternoon
Ely Lilly Shares Are Trading Higher After the FDA Approved the Company's Zepbound, a Weight Loss Drug Designed to Treat Moderate-to-severe Obstructive Sleep Apnea in Adults With Obesity.
Eli Lilly Stock Is Rising Monday: What's Going On?
These Stocks Are Moving the Most Today: Honda, Qualcomm, Broadcom, Lilly, ResMed, Tesla, Walmart, Rumble, and More -- Barrons.com
Lilly, Amgen Sue HHS Over Certification of Drug Discount Program Recipients
Express News | Lilly: Will Continue to Pursue Appropriate Legal Avenues Against Those Importing Illicit Tirzepatide Knockoffs - Website
Express News | Lilly: Judge Overseeing Itc Case Determined U.S. Customs and Border Protection Should Prevent Illicit Import of Knock-off Tirzepatide Products
Express News | US FDA: Revoked Emergency Use Authorization for Lilly's Bebtelovimab as of Dec 13 - Website
ResMed, Inspire Medical Fall After Lilly's Zepbound Gains Sleep Apnea Indication
Sector Update: Health Care Stocks Fall Premarket Monday
Does Eli Lilly (NYSE:LLY) Deserve A Spot On Your Watchlist?